APA (7th ed.) Citation

Thapa, D., Patil, M., Warne, L. N., Carlessi, R., & Falasca, M. (2025). Enhancing Tetrahydrocannabinol’s Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011. Pharmaceuticals (Basel, Switzerland), 18(2), 148. https://doi.org/10.3390/ph18020148

Chicago Style (17th ed.) Citation

Thapa, Dinesh, Mohan Patil, Leon N. Warne, Rodrigo Carlessi, and Marco Falasca. "Enhancing Tetrahydrocannabinol’s Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011." Pharmaceuticals (Basel, Switzerland) 18, no. 2 (2025): 148. https://doi.org/10.3390/ph18020148.

MLA (9th ed.) Citation

Thapa, Dinesh, et al. "Enhancing Tetrahydrocannabinol’s Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011." Pharmaceuticals (Basel, Switzerland), vol. 18, no. 2, 2025, p. 148, https://doi.org/10.3390/ph18020148.